Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes

  • Jennifer M. Kalish
  • , Kerri D. Becktell
  • , Gaëlle Bougeard
  • , Garrett M. Brodeur
  • , Lisa R. Diller
  • , Andrea S. Doria
  • , Jordan R. Hansford
  • , Steven D. Klein
  • , Wendy K. Kohlmann
  • , Christian P. Kratz
  • , Suzanne P. MacFarland
  • , Kristian W. Pajtler
  • , Surya P. Rednam
  • , Jaclyn Schienda
  • , Lisa J. States
  • , Anita Villani
  • , Rosanna Weksberg
  • , Kristin Zelley
  • , Gail E. Tomlinson
  • , Jack J. Brzezinski

Research output: Contribution to journalReview articlepeer-review

23 Citations (Scopus)

Abstract

Wilms tumors are commonly associated with predisposition syndromes, many but not all of which include overgrowth. Several of these syndromes also include a risk of other embryonal malignancies- particularly hepatoblastoma. Guidelines for surveillance in this population were published in 2017, and recently, members of the American Association for Cancer Research Pediatric Cancer Working Group met to update those guidelines with a review of more recently published evidence and risk estimates. This perspective serves to update pediatric oncologists, geneticists, radiologists, counselors, and other health care professionals on revised diagnostic criteria; review previously published surveillance guidelines; and harmonize updated surveillance recommendations in the North American and Australian contexts for patients with overgrowth syndromes and other syndromes associated with Wilms tumor predisposition.

Original languageEnglish
Pages (from-to)5260-5269
Number of pages10
JournalClinical Cancer Research
Volume30
Issue number23
DOIs
Publication statusPublished or Issued - 1 Dec 2024
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Cite this